Democrats are calling on GOP leaders to discard Medicaid cuts and as an alternative deal with Medicare Benefit “upcoding” to sort out federal waste. In a letter to Senate Majority Chief John Thune and Home Speaker Mike Johnson, greater than 40 lawmakers known as for motion in opposition to personal insurers tampering with affected person diagnoses to extend income.
What Occurred: The lawmakers cited studies that Medicare overpaid personal insurers by $50 billion in 2024 for unverified diagnoses, as per The Hill. “The place there may be widespread settlement is the necessity to deal with waste, fraud, and abuse by personal, for-profit insurance coverage firms,” they wrote, referring to $83 billion in extra funds as compared with conventional Medicare.
See Additionally: Pope Leo XIV Didn’t Spare Trump Administration Criticism On Social Media — Now The President Says He’s ‘Excited’ And Wanting Ahead To Assembly The First American Catholic Pontiff
Why It Issues: The funds cuts sought by Republicans may hurt working-class People who depend upon welfare packages for healthcare entry, in response to Democrats. “Transferring ahead with this harmful plan… can be a man-made catastrophe for the well being of the nation and the financial system,” the letter says.
A brand new Congressional Price range Workplace evaluation signifies that Republican funds proposals may take away Medicaid protection from 2.3 to eight.6 million People. The plans embrace reducing funds to states that expanded Medicaid beneath the ACA. This might doubtlessly depart 5.5 million with out protection by 2034, together with 2.4 million who would lose all medical insurance.
Final month, President Donald Trump mentioned he would veto any laws that reduces Social Safety or federal well being packages, emphasizing that the one reforms he helps are these addressing “waste, fraud and abuse” in Medicaid.
Learn Subsequent:
Social Safety Will get A Fashionable Makeover: Right here’s What It Means for Your SSN
Picture By way of Shutterstock
Market Information and Information delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
